学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
PRODRUGS FOR THE IMPROVEMENT OF DRUG ABSORPTION VIA DIFFERENT ROUTES OF ADMINISTRATION
被引:30
作者
:
BALANT, LP
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV GENEVA, DEPT PSYCHIAT, CH-1211 GENEVA 4, SWITZERLAND
BALANT, LP
DOELKER, E
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV GENEVA, DEPT PSYCHIAT, CH-1211 GENEVA 4, SWITZERLAND
DOELKER, E
BURI, P
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV GENEVA, DEPT PSYCHIAT, CH-1211 GENEVA 4, SWITZERLAND
BURI, P
机构
:
[1]
UNIV GENEVA, DEPT PSYCHIAT, CH-1211 GENEVA 4, SWITZERLAND
[2]
UNIV GENEVA, SCH PHARM, CH-1211 GENEVA 4, SWITZERLAND
来源
:
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
|
1990年
/ 15卷
/ 02期
关键词
:
absorption improvement;
bioavailability;
drugs;
ocular route;
oral route;
parenteral route;
Pro;
transdermal route;
D O I
:
10.1007/BF03190197
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
The authors critically review recent knowledge on the use of prodrugs to improve drug absorption. Main emphasis is placed on the parenteral, oral, transdermal and ocular routes. Mechanisms for drug absorption enhancement and bioavailability assessment are discussed. Some other applications of prodrugs are also examined. Finally, some comments are made regarding the present situation and future trends in prodrug design and their implications in biopharmaceutics and pharmacokinetics. © 1990 Springer-Verlag.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 111 条
[1]
DISSOLUTION BEHAVIOR OF POLYMORPHS OF CHLORAMPHENICOL PALMITATE AND MEFENAMIC ACID
AGUIAR, AJ
论文数:
0
引用数:
0
h-index:
0
机构:
Product Development Department, Division of Medical and Scientific Affairs, Parke, Davis & Company, Detroit, Michigan
AGUIAR, AJ
ZELMER, JE
论文数:
0
引用数:
0
h-index:
0
机构:
Product Development Department, Division of Medical and Scientific Affairs, Parke, Davis & Company, Detroit, Michigan
ZELMER, JE
[J].
JOURNAL OF PHARMACEUTICAL SCIENCES,
1969,
58
(08)
: 983
-
+
[2]
CHEMICAL ASPECTS OF SELECTIVE TOXICITY
ALBERT, A
论文数:
0
引用数:
0
h-index:
0
ALBERT, A
[J].
NATURE,
1958,
182
(4633)
: 421
-
423
[3]
REDUCTION OF 1ST-PASS METABOLISM OF PROPRANOLOL AFTER ORAL-ADMINISTRATION OF ESTER PRODRUGS
ANDERSON, BD
论文数:
0
引用数:
0
h-index:
0
ANDERSON, BD
CHU, WW
论文数:
0
引用数:
0
h-index:
0
CHU, WW
GALINSKY, RE
论文数:
0
引用数:
0
h-index:
0
GALINSKY, RE
[J].
INTERNATIONAL JOURNAL OF PHARMACEUTICS,
1988,
43
(03)
: 261
-
265
[4]
PRODRUGS FOR IMPROVED ORAL NALBUPHINE BIOAVAILABILITY - INTERSPECIES DIFFERENCES IN THE DISPOSITION OF NALBUPHINE AND ITS ACETYLSALICYLATE AND ANTHRANILATE ESTERS
AUNGST, BJ
论文数:
0
引用数:
0
h-index:
0
AUNGST, BJ
MYERS, MJ
论文数:
0
引用数:
0
h-index:
0
MYERS, MJ
SHEFTER, E
论文数:
0
引用数:
0
h-index:
0
SHEFTER, E
SHAMI, EG
论文数:
0
引用数:
0
h-index:
0
SHAMI, EG
[J].
INTERNATIONAL JOURNAL OF PHARMACEUTICS,
1987,
38
(1-3)
: 199
-
209
[5]
ANTIPSYCHOTIC-DRUGS - CLINICAL PHARMACOKINETICS OF POTENTIAL CANDIDATES FOR PLASMA-CONCENTRATION MONITORING
BALANTGORGIA, AE
论文数:
0
引用数:
0
h-index:
0
BALANTGORGIA, AE
BALANT, L
论文数:
0
引用数:
0
h-index:
0
BALANT, L
[J].
CLINICAL PHARMACOKINETICS,
1987,
13
(02)
: 65
-
90
[6]
SYNTHESIS AND KINETIC STABILITY STUDIES OF PROGESTERONE DERIVATIVES
BASU, K
论文数:
0
引用数:
0
h-index:
0
机构:
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
BASU, K
KILDSIG, DO
论文数:
0
引用数:
0
h-index:
0
机构:
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
KILDSIG, DO
MITRA, AK
论文数:
0
引用数:
0
h-index:
0
机构:
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
MITRA, AK
[J].
INTERNATIONAL JOURNAL OF PHARMACEUTICS,
1988,
47
(1-3)
: 195
-
203
[7]
BIASIO RB, 1989, CLIN PHARMACOKINET, V16, P215
[8]
COMPARISON OF THE OCULAR HYPOTENSIVE EFFICACY OF EICOSANOIDS AND RELATED-COMPOUNDS
BITO, LZ
论文数:
0
引用数:
0
h-index:
0
BITO, LZ
[J].
EXPERIMENTAL EYE RESEARCH,
1984,
38
(02)
: 181
-
194
[9]
IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .4. PRODRUGS OF L-DOPA
BODOR, N
论文数:
0
引用数:
0
h-index:
0
机构:
INTER RES CORP,LAWRENCE,KS 66044
BODOR, N
SLOAN, KB
论文数:
0
引用数:
0
h-index:
0
机构:
INTER RES CORP,LAWRENCE,KS 66044
SLOAN, KB
HIGUCHI, T
论文数:
0
引用数:
0
h-index:
0
机构:
INTER RES CORP,LAWRENCE,KS 66044
HIGUCHI, T
SASAHARA, K
论文数:
0
引用数:
0
h-index:
0
机构:
INTER RES CORP,LAWRENCE,KS 66044
SASAHARA, K
[J].
JOURNAL OF MEDICINAL CHEMISTRY,
1977,
20
(11)
: 1435
-
1445
[10]
Bodor N, 1984, Pharm Res, V1, P168, DOI 10.1023/A:1016348624897
←
1
2
3
4
5
6
7
8
9
10
→
共 111 条
[1]
DISSOLUTION BEHAVIOR OF POLYMORPHS OF CHLORAMPHENICOL PALMITATE AND MEFENAMIC ACID
AGUIAR, AJ
论文数:
0
引用数:
0
h-index:
0
机构:
Product Development Department, Division of Medical and Scientific Affairs, Parke, Davis & Company, Detroit, Michigan
AGUIAR, AJ
ZELMER, JE
论文数:
0
引用数:
0
h-index:
0
机构:
Product Development Department, Division of Medical and Scientific Affairs, Parke, Davis & Company, Detroit, Michigan
ZELMER, JE
[J].
JOURNAL OF PHARMACEUTICAL SCIENCES,
1969,
58
(08)
: 983
-
+
[2]
CHEMICAL ASPECTS OF SELECTIVE TOXICITY
ALBERT, A
论文数:
0
引用数:
0
h-index:
0
ALBERT, A
[J].
NATURE,
1958,
182
(4633)
: 421
-
423
[3]
REDUCTION OF 1ST-PASS METABOLISM OF PROPRANOLOL AFTER ORAL-ADMINISTRATION OF ESTER PRODRUGS
ANDERSON, BD
论文数:
0
引用数:
0
h-index:
0
ANDERSON, BD
CHU, WW
论文数:
0
引用数:
0
h-index:
0
CHU, WW
GALINSKY, RE
论文数:
0
引用数:
0
h-index:
0
GALINSKY, RE
[J].
INTERNATIONAL JOURNAL OF PHARMACEUTICS,
1988,
43
(03)
: 261
-
265
[4]
PRODRUGS FOR IMPROVED ORAL NALBUPHINE BIOAVAILABILITY - INTERSPECIES DIFFERENCES IN THE DISPOSITION OF NALBUPHINE AND ITS ACETYLSALICYLATE AND ANTHRANILATE ESTERS
AUNGST, BJ
论文数:
0
引用数:
0
h-index:
0
AUNGST, BJ
MYERS, MJ
论文数:
0
引用数:
0
h-index:
0
MYERS, MJ
SHEFTER, E
论文数:
0
引用数:
0
h-index:
0
SHEFTER, E
SHAMI, EG
论文数:
0
引用数:
0
h-index:
0
SHAMI, EG
[J].
INTERNATIONAL JOURNAL OF PHARMACEUTICS,
1987,
38
(1-3)
: 199
-
209
[5]
ANTIPSYCHOTIC-DRUGS - CLINICAL PHARMACOKINETICS OF POTENTIAL CANDIDATES FOR PLASMA-CONCENTRATION MONITORING
BALANTGORGIA, AE
论文数:
0
引用数:
0
h-index:
0
BALANTGORGIA, AE
BALANT, L
论文数:
0
引用数:
0
h-index:
0
BALANT, L
[J].
CLINICAL PHARMACOKINETICS,
1987,
13
(02)
: 65
-
90
[6]
SYNTHESIS AND KINETIC STABILITY STUDIES OF PROGESTERONE DERIVATIVES
BASU, K
论文数:
0
引用数:
0
h-index:
0
机构:
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
BASU, K
KILDSIG, DO
论文数:
0
引用数:
0
h-index:
0
机构:
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
KILDSIG, DO
MITRA, AK
论文数:
0
引用数:
0
h-index:
0
机构:
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
MITRA, AK
[J].
INTERNATIONAL JOURNAL OF PHARMACEUTICS,
1988,
47
(1-3)
: 195
-
203
[7]
BIASIO RB, 1989, CLIN PHARMACOKINET, V16, P215
[8]
COMPARISON OF THE OCULAR HYPOTENSIVE EFFICACY OF EICOSANOIDS AND RELATED-COMPOUNDS
BITO, LZ
论文数:
0
引用数:
0
h-index:
0
BITO, LZ
[J].
EXPERIMENTAL EYE RESEARCH,
1984,
38
(02)
: 181
-
194
[9]
IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .4. PRODRUGS OF L-DOPA
BODOR, N
论文数:
0
引用数:
0
h-index:
0
机构:
INTER RES CORP,LAWRENCE,KS 66044
BODOR, N
SLOAN, KB
论文数:
0
引用数:
0
h-index:
0
机构:
INTER RES CORP,LAWRENCE,KS 66044
SLOAN, KB
HIGUCHI, T
论文数:
0
引用数:
0
h-index:
0
机构:
INTER RES CORP,LAWRENCE,KS 66044
HIGUCHI, T
SASAHARA, K
论文数:
0
引用数:
0
h-index:
0
机构:
INTER RES CORP,LAWRENCE,KS 66044
SASAHARA, K
[J].
JOURNAL OF MEDICINAL CHEMISTRY,
1977,
20
(11)
: 1435
-
1445
[10]
Bodor N, 1984, Pharm Res, V1, P168, DOI 10.1023/A:1016348624897
←
1
2
3
4
5
6
7
8
9
10
→